3-hydroxypyridine has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhunzyanov, AA; Balakin, KV; Gabbasova, RR; Iksanova, AG; Kupriyanova, TV; Pugachev, MV; Shtyrlin, NV; Shtyrlin, YG; Vafiva, RM | 1 |
1 other study(ies) available for 3-hydroxypyridine and Ovarian Neoplasms
| Article | Year |
|---|---|
In-vitro antitumor activity of new quaternary phosphonium salts, derivatives of 3-hydroxypyridine.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Female; Fibroblasts; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Organophosphorus Compounds; Ovarian Neoplasms; Pyridines; Tumor Stem Cell Assay | 2018 |